NeuroMetrix, a medical device company, and Omron Medical Devices, a subsidiary of Omron Healthcare China, have entered into an agreement for the distribution of NC-stat DPNCheck in China. Pursuant to the terms of the agreement, ...
Tags: Medical Devices, Medicine
NeuroMetrix, a US-based medical device company, has received 510(k) approval from the US Food and Drug Administration (FDA) for its transcutaneous electrical nerve stimulator, called Sensus Pain Management System. Sensus Pain Management ...
Tags: medical device, Pain Management
Omron Healthcare has entered into an agreement to distribute NeuroMetrix's NC-stat DPNCheck in Japan. Designed to detect diabetic peripheral neuropathy at an early stage, the quantitative point-of-care test NC-stat DPNCheckmn allows ...
California-based technology-enabled service company FirstVitals Health and Wellness has received a non-invasive technology, designed for diagnosis of diabetic neuropathy, from NeuroMetrix to supplement its Centers for Medicare and Medicaid ...
Tags: NeuroMetrix, diagnostic technology, FirstVitals Health
The US Food and Drug Administration (FDA) has granted 510(k) clearance to NeuroMetrix's Sensus pain management system, designed as a treatment for painful diabetic neuropathy. The Sensus system is designed for use as a non-invasive ...
OneSource Medical Group in Florida has entered into an agreement to distribute NeuroMetrix's transcutaneous electrical nerve stimulator, designed to help manage chronic pain in diabetes patients with painful diabetic neuropathy. The ...
Tags: OneSource, agreement, NeuroMetrix